UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic value of KRAS G12V mutation in lung adenocarcinoma stratified by stages and radiological features

The Journal of thoracic and cardiovascular surgery, 2024-03

2024

Volltextzugriff (PDF)

KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

Lung cancer (Amsterdam, Netherlands), 2021-04, Vol.154, p.51-61

2021

Volltextzugriff (PDF)

Subtyping of advanced lung cancer based on PD-L1 expression, tumor histopathology and mutation burden (EGFR and KRAS): a study from North India

Monaldi archives for chest disease, 2023-02, Vol.93 (4)

2023

Volltextzugriff (PDF)

Prognostic value of KRAS G12C mutation in lung adenocarcinoma stratified by stages and radiological features

The Journal of thoracic and cardiovascular surgery, 2023-12, Vol.166 (6), p.e479-e499

2023

Volltextzugriff (PDF)

KRAS G12C mutated advanced non-small cell lung cancer (NSCLC): Characteristics, treatment patterns and overall survival from a Danish nationwide observational register study

Lung cancer (Amsterdam, Netherlands), 2023-04, Vol.178, p.172-182

2023

Volltextzugriff (PDF)

KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness in Synchronous Metastatic Colorectal Cancer (mCRC): Retrospective Research

OncoTargets and therapy, 2020-01, Vol.13, p.12601-12613

2020

Volltextzugriff (PDF)

Real world outcomes in KRAS G12C mutation positive non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2020-08, Vol.146, p.310-317

2020

Volltextzugriff (PDF)

Dissecting the Clinical Characteristics and Treatment Outcomes Correlates of KRAS G12C -Mutated Non-Small Cell Lung Cancer

International journal of general medicine, 2024-10, Vol.17, p.4507-4517

2024

Volltextzugriff (PDF)

KRAS -G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal Cancer

Frontiers in oncology, 2022-02, Vol.12, p.826073-826073

2022

Volltextzugriff (PDF)

Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2015-11, Vol.90 (2), p.249-254

2015

Volltextzugriff (PDF)

Clinical characteristics and prognostic value of the KRAS G12C mutation in Chinese non-small cell lung cancer patients

Biomarker research, 2020-06, Vol.8 (1), p.22-22, Article 22

2020

Volltextzugriff (PDF)

Performance Evaluation Comparison of 3 Commercially Available PCR-based KRAS Mutation Testing Platforms

Applied immunohistochemistry & molecular morphology, 2014-03, Vol.22 (3), p.231-235

2014

Volltextzugriff (PDF)

Second‐Line Therapy for Advanced NSCLC

The oncologist (Dayton, Ohio), 2013-08, Vol.18 (8), p.947-953

2013

Volltextzugriff (PDF)

Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS‐mutant cancer

EMBO molecular medicine, 2021-09, Vol.13 (9), p.e13193-n/a

2021

Volltextzugriff (PDF)

Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC)

Journal of thoracic oncology, 2019-06, Vol.14 (6), p.1095-1101

2019

Volltextzugriff (PDF)

Multiplex detection of KRAS mutations by a matrix-assisted laser desorption/ionization-time of flight mass spectrometry assay

Clinical biochemistry, 2014-08, Vol.47 (12), p.1091-1097

2014

Volltextzugriff (PDF)

KRAS-Mutant non-small cell lung cancer: From biology to therapy

Lung cancer (Amsterdam, Netherlands), 2018-10, Vol.124, p.53-64

2018

Volltextzugriff (PDF)

Molecular epidemiology and diagnostics of KRAS mutations in human cancer

Cancer and metastasis reviews, 2020-12, Vol.39 (4), p.1029-1038

2020

Volltextzugriff (PDF)

Targeting KRAS mutant cancers: from druggable therapy to drug resistance

Molecular cancer, 2022-08, Vol.21 (1), p.1-159, Article 159

2022

Volltextzugriff (PDF)

Targeted Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer. An Update on Treatment of the Most Important Actionable Oncogenic Driver Alterations

Cancers, 2021-02, Vol.13 (4), p.804

2021

Volltextzugriff (PDF)

Therapeutics Targeting Mutant KRAS

Annual review of medicine, 2021-01, Vol.72 (1), p.349-364

2021

Volltextzugriff (PDF)

Mesonephric-like Endometrial Carcinoma: Results From Immunohistochemical Screening of 300 Endometrial Carcinomas and Carcinosarcomas for This Often Overlooked and Potentially Aggressive Entity

The American journal of surgical pathology, 2022-07, Vol.46 (7), p.921-932

2022

Volltextzugriff (PDF)

Drugging the undruggable: Advances in targeting KRAS signaling in solid tumors

International review of cell and molecular biology, 2024, Vol.385, p.1-39

2024

Volltextzugriff (PDF)

KRAS G12D mutation eliminates reactive oxygen species through the Nrf2/CSE/H 2S axis and contributes to pancreatic cancer growth

Acta biochimica et biophysica Sinica, 2022-11, Vol.54 (11), p.1731-1739

2022

Volltextzugriff (PDF)

Mutation analysis of papillary tubal hyperplasia associated with ovarian atypical proliferative serous tumor and low-grade serous carcinoma

American journal of obstetrics and gynecology, 2013-08, Vol.209 (2), p.e6-e8

2013

Volltextzugriff (PDF)

1 – 25 von 3.595

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.258)
Mit Volltextzugriff
(3.206)

Publikationsform

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.269)
Life Sciences & Biomedicine
(3.165)
Mutation
(2.669)
Humans
(2.329)
Kras
(2.244)
Oncology
(1.749)
Female
(1.247)
Male
(1.117)
Tumors
(1.106)
Proto-Oncogene Proteins P21 - Genetics
(1.071)
Colorectal Cancer
(1.040)
Middle Aged
(995)
Aged
(907)
Ras Proteins - Genetics
(770)
Proto-Oncogene Proteins - Genetics
(709)
Proto-Oncogene Proteins P21
(706)
Adult
(693)
Colorectal Neoplasms - Genetics
(690)
Kras Mutation
(640)
K-Ras Protein
(629)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancers
(128)
International Journal Of Molecular Sciences
(82)
Lung Cancer
(79)
Bmc Cancer
(75)
Oncotarget
(66)
Journal Of Thoracic Oncology
(62)
International Journal Of Cancer
(55)
Anticancer Research
(54)
Human Pathology
(52)
Frontiers In Oncology
(45)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(34)
... seit 30 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Prognostic value of KRAS G12V mutation in lung adenocarcinoma stratified by stages and radiological features

KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

Subtyping of advanced lung cancer based on PD-L1 expression, tumor histopathology and mutation burden (EGFR and KRAS): a study from North India

Prognostic value of KRAS G12C mutation in lung adenocarcinoma stratified by stages and radiological features

KRAS G12C mutated advanced non-small cell lung cancer (NSCLC): Characteristics, treatment patterns and overall survival from a Danish nationwide observational register study

KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness in Synchronous Metastatic Colorectal Cancer (mCRC): Retrospective Research

Real world outcomes in KRAS G12C mutation positive non-small cell lung cancer

Dissecting the Clinical Characteristics and Treatment Outcomes Correlates of KRAS G12C -Mutated Non-Small Cell Lung Cancer

KRAS -G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal Cancer

Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer

Clinical characteristics and prognostic value of the KRAS G12C mutation in Chinese non-small cell lung cancer patients

Performance Evaluation Comparison of 3 Commercially Available PCR-based KRAS Mutation Testing Platforms

Second‐Line Therapy for Advanced NSCLC

Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS‐mutant cancer

Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC)

Multiplex detection of KRAS mutations by a matrix-assisted laser desorption/ionization-time of flight mass spectrometry assay

KRAS-Mutant non-small cell lung cancer: From biology to therapy

Molecular epidemiology and diagnostics of KRAS mutations in human cancer

Targeting KRAS mutant cancers: from druggable therapy to drug resistance

Targeted Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer. An Update on Treatment of the Most Important Actionable Oncogenic Driver Alterations

Therapeutics Targeting Mutant KRAS

Mesonephric-like Endometrial Carcinoma: Results From Immunohistochemical Screening of 300 Endometrial Carcinomas and Carcinosarcomas for This Often Overlooked and Potentially Aggressive Entity

Drugging the undruggable: Advances in targeting KRAS signaling in solid tumors

KRAS G12D mutation eliminates reactive oxygen species through the Nrf2/CSE/H 2S axis and contributes to pancreatic cancer growth

Mutation analysis of papillary tubal hyperplasia associated with ovarian atypical proliferative serous tumor and low-grade serous carcinoma

Suchergebnisse filtern